MarketsStocksNATCOPHARM
NA

NATCO PHARMA

NSE: NATCOPHARMBSE: 524816Healthcare
Download Research Report7-page PDF
870.00
-2.62%
NSE · auto-updates while market open
Prev Close
₹858.30
Day High
₹908.30
Day Low
₹863.30
Mkt Cap
₹15,269 Cr
P / E
10.8
P / B
1.6
ROE
16.9%
52W High
₹1,226.80
52W Low
₹789.00
Key Metrics
Market Cap
₹15,269 Cr
P / E
10.76
P / B
1.65
EV / EBITDA
10.54
ROCE
17.2%
ROE
16.9%
Debt / Equity
0.08
Book Value
₹515.15
EPS
₹79.20
Div Yield
0.6%
Face Value
₹2
Promoter Holding
49.4%
Revenue · ₹ Cr
1.9k
FY20
2.1k
FY21
1.9k
FY22
2.7k
FY23
4.0k
FY24
4.4k
FY25
4.1k
FY26
Net Profit · ₹ Cr
458
FY20
442
FY21
170
FY22
715
FY23
1.4k
FY24
1.9k
FY25
1.4k
FY26
EPS · ₹ per share
₹25.3
FY20
₹24.2
FY21
₹9.3
FY22
₹39.2
FY23
₹77.3
FY24
₹105.3
FY25
₹79.2
FY26
P / E Ratio · price ÷ TTM EPS
0336699120560-8Jun 21Feb 23Oct 24Jun 26
P/E 11.0×Median 19.8×TTM EPS
Q1 2026 snapshot
Sales
₹817 Cr
Operating profit
-
OPM
-
Net profit
₹269 Cr
EPS
₹14.96
Scorecard · 7 axes
Quality
Strong
86/100
Valuation
Strong
10.8×
Growth
Strong
+45.1%
Profitability
Good
17.0%
Performance
Weak
+3.7%
Entry Point
Good
71%
Red Flags
Strong
0 flags
Shareholding Pattern
49.4%Promoter
Promoter49.4%
FII17.4%
DII5.5%
Public27.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue4751,287.31,390.61,463705.4816.9
Net Profit132406480.3517.9151.3269
NPM %27.8%31.5%34.5%35.4%21.4%32.9%
AlertPre-trade